| 发明名称 |
SYNERGISTICALLY EFFECTIVE COMBINATIONS OF DIHALOACETAMIDE COMPOUNDS AND INTERFERON OR RIBAVIRIN AGAINST HCV INFECTIONS |
| 摘要 |
The present invention relates to anti-HCV dihaloacetamide compounds in synergistic combination with an interferon and/or ribavirin and pharmaceutical compositions thereof for inhibition of the replication of HCV virus. The present invention also relates to the use of the compositions to inhibit HCV replication and/or proliferation and to treat or prevent HCV infections. |
| 申请公布号 |
WO2005049065(A2) |
申请公布日期 |
2005.06.02 |
| 申请号 |
WO2004US39011 |
申请日期 |
2004.11.19 |
| 申请人 |
RIGEL PHARMACEUTICALS, INC.;LU, HENRY |
发明人 |
LU, HENRY |
| 分类号 |
A61K31/16;A61K31/42;A61K31/4439;A61K31/7056;A61K38/21;A61K45/06 |
主分类号 |
A61K31/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
